Infliximab treatment for refractory Kawasaki disease with coronary artery aneurysm. |
| |
| Authors: | Taku Oishi Mikiya Fujieda Taisuke Shiraishi Miki Ono Kazuo Inoue Akiyoshi Takahashi Hideo Ogura Hiroshi Wakiguchi |
| |
| Affiliation: | Department of Pediatrics, Kochi National Hospital, Kochi, Japan. |
| |
| Abstract: | Tumor necrosis factor-alpha (TNF-alpha) is considered to be 1 of the factors that induce vasculitis, including coronary artery aneurysm (CA), in Kawasaki disease (KD), because the blood concentration of TNF-alpha is higher in patients with CA compared with those without. Therefore, an anti-TNF-alphaagent (infliximab) was administered to a 1-month-old girl with refractory KD complicated by CA and subsequently, the CA improved and KD was controlled without complications 20 months after the onset. |
| |
| Keywords: | |
|
|
